Page 38 - Urology Update for Primary Care Physicians for 2013

© The Canadian Journal of Urology™; 19(Supplement 1); October 2012
31.
Liu, PY, Swerdloff RS, Veldhuis JD. Clinical review 171: the
rationale, efficacy and safety of androgen therapy in older men:
future research and current practice recommendations.
J Clin
Endocrinol Metab
2004;89(10):4789-4796.
32.
Zitzmann M, Faber S, Nieschlag E. Association of specific
symptoms andmetabolic risks with serum testosterone in older
men.
J Clin Endocrinol Metab
2006;91(11):4335-4343.
33.
Bhasin S, CunninghamGR, Hayes FJ et al. Testosterone therapy
in adult menwith androgen deficiency syndrome: an endocrine
societyclinicalpracticeguideline.
JClinEndocrinolMetab
2006;91(6):
1995-2010.
34.
MoralesA, BellaAJ, Chun S et al. Apractical guide to diagnosis,
management and treatment of testosterone deficiency for
Canadian physicians.
Can Urol Assoc J
2010;4(4):269-275.
35.
DhindsaS,PrabhakarS,SethiM,BandyopadhyayA,ChaudhuriA,
Dandona P. Frequent occurrence of hypogonadotropic
hypogonadism in type 2 diabetes.
J Clin Endocrinol Metab
2004;89(11):5462-5468.
36.
Canadian Diabetes Association Clinical Practice Guidelines
Expert Committee. Canadian DiabetesAssociation 2008 clinical
practice guidelines for the prevention and management of
diabetes in Canada.
Can J Diabetes
2008;32:
S1-S201.
37.
Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous
sex hormones and risk of type 2 diabetes: a systematic review
and meta-analysis.
JAMA
2006;295(11):1288-1299.
38.
O’Donnell AB, AraujoAB, McKinlay JB. The health of normally
aging men: The Massachusetts Male Aging Study (1987-2004).
Exp Gerontol
2004;39(7):975-984.
39.
Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and
management of the metabolic syndrome: an American Heart
Association/National Heart, Lung, and Blood Institute Scientific
Statement.
Circulation
2005;112(17):2735-2752.
40.
Shores MM, Matsumoto AM, Sloan KL et al. Low serum
testosterone and mortality in male veterans.
Arch Int Med
2006;
166(15):1660-1665.
41.
Morgentaler A. Testosterone and prostate cancer: an historical
perspective on a modern myth.
Eur Urol
2006;50(5):935-939.
42.
Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D.
Bioavailable testosterone and depressed mood in older men: the
RanchoBernardo Study.
J ClinEndocrinolMetab
1999;84(2):573-577.
27
Erectile dysfunction and testosterone deficiency syndrome: the “portal to men’s health”